Sean Kim
Stock Analyst at JonesTrading
(0.50)
# 3,887
Out of 4,739 analysts
8
Total ratings
33.33%
Success rate
-14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $0.84 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $13.71 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $0.95 | +528.40% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $0.70 | +753.49% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $8.72 | +198.17% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $3.78 | +85.19% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.84
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $13.71
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.95
Upside: +528.40%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.70
Upside: +753.49%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $8.72
Upside: +198.17%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $3.78
Upside: +85.19%